-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$18.8375.65% Upside
Cogent Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. has been rated by research analysts at Citigroup, H.C. Wainwright, Jefferies, Needham, Raymond James, Leerink Partners in the past 90 days.